Ignite Creation Date:
2025-12-24 @ 11:57 PM
Ignite Modification Date:
2026-01-17 @ 8:54 PM
Study NCT ID:
NCT02500251
Status:
COMPLETED
Last Update Posted:
2019-04-22
First Post:
2015-07-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Belimumab Impacting Transplant Eligibility
Sponsor:
E. Steve Woodle
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Belimumab
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |